CSPC Innovation Pharmaceutical Hits Day Low Amid Price Pressure at CNY 47.38

CSPC Innovation Pharmaceutical Co., Ltd. experienced significant volatility on September 26, 2025, with the stock hitting an intraday low of CNY 47.38, reflecting a decline of 5.87% for the day. This performance stands in contrast to the China Shanghai Composite, which saw a modest decrease of 0.65%.
Over the past week, CSPC's stock has dropped 6.24%, and its monthly performance shows a decline of 10.76%. Despite these short-term challenges, the company has demonstrated remarkable growth over the past year, with a return of 86.32%, significantly outperforming the broader market index, which gained 27.56%.

However, the company faces ongoing difficulties, as evidenced by a consistent trend of negative results over the last six quarters. Key financial metrics indicate a concerning decline in net sales, which fell by 5.88%, and a substantial drop in pre-tax profit and net profit. The company's current market capitalization stands at CNY 62,266 million, and it operates within the FMCG sector, characterized by a high price-to-book ratio of 16.80.